Tag: Glenmark

Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. It is a research driven global pharmaceutical organization focused on discovering novel molecules and developing high-quality generics and specialty products for markets across the globe. Glenmark has 17 manufacturing facilities across 5 countries including US, Argentina, Czech Republic and India. Glenmark has 5 R&D centers around the world engaged in discovery of novel biological and chemical entities.

Glenmark Pharma launched its asthma drug generic in Denmark

glenmark
Glenmark Pharmaceuticals Europe has launched a generic version of Seretide Accuhaler, used to treat asthma, in Denmark. The product was developed by Celon Pharma.

Glenmark entered exclusive agreement with Cyndea Pharma

glenmark
Glenmark Pharmaceuticals, a global pharmaceutical company, yesterday announced it has entered into a development, license, manufacture and commercial supply agreement with Spanish company Cyndea Pharma S.L.

Glenmark made a licensing agreement with APC Therapeutics

glenmark
Glenmark Pharmaceuticals informed it has entered into an agreement with Boston‐based biopharmaceutical firm APC Therapeutics to in-license the latter’s novel immune-oncology molecule

Glenmark obtained FDA approval for hypertension drug

glenmark
Glenmark Pharmaceuticals stated in a regulatory filing that it received final FDA approval for its generic version of Forest Laboratories' hypertension treatment Bystolic

FDA approved Glenmark’s generic drug

fda office
Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (FDA) for fenofibrate capsules USP, 67 mg, 134 mg and 200 mg, the generic version of Tricor...